|
|
||||||||
NEUROHUMORAL CONTROL OF CARDIOVASCULAR FUNCTION
Departments of 1Molecular and Cellular Physiology, and 2Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio
Submitted 1 February 2006 ; accepted in final form 15 September 2006
There is growing evidence that sphingosine 1-phosphate (S1P) plays an important role in regulating the development, morphology, and function of the cardiovascular system. There is little data, however, regarding the relative contribution of endogenous S1P and its cognate receptors (referred to as S1P15) to cardiovascular homeostasis. We used S1P2 receptor knockout mice (S1P2/) to evaluate the role of S1P2 in heart and vascular function. There were no significant differences in blood pressure between wild-type and S1P2/ mice, measured in awake mice. Cardiac function, evaluated in situ by using a Millar catheter, was also not different in S1P2/ mice under baseline or stimulated conditions. In vivo analysis of vascular function by flowmetry revealed decreases in mesenteric and renal resistance in S1P2/ mice, especially during vasoconstriction with phenylephrine. In intact aortic rings, the concentration-force relations for both KCl and phenylephrine were right shifted in S1P2/ mice, whereas the maximal isometric forces were not different. By contrast, in deendothelialized rings the concentration-force relations were not different but the maximal force was significantly greater in S1P2/ aorta. Histologically, there were no apparent differences in vascular morphology. These data suggest that the S1P2 receptor plays an important role in the function of the vasculature and is an important mediator of normal hemodynamics. This is mediated, at least in part, through an effect on the endothelium, but direct effects on vascular smooth muscle cannot be ruled out and require further investigation.
lysosphingolipids; endothelium; vascular smooth muscle; blood flow; myocardial contractility
This article has been cited by other articles:
![]() |
B. Levkau Sphingosine-1-Phosphate in the Regulation of Vascular Tone: A Finely Tuned Integration System of S1P Sources, Receptors, and Vascular Responsiveness Circ. Res., August 1, 2008; 103(3): 231 - 233. [Full Text] [PDF] |
||||
![]() |
R. Rexhepaj, K. M. Boini, D. Y. Huang, K. Amann, F. Artunc, K. Wang, J. J. Brosens, D. Kuhl, and F. Lang Role of maternal glucocorticoid inducible kinase SGK1 in fetal programming of blood pressure in response to prenatal diet Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2008; 294(6): R2008 - R2013. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Xu, O. Platoshyn, A. Makino, W. H. Dillmann, K. Akassoglou, C. V. Remillard, and J. X.-J. Yuan Characterization of agonist-induced vasoconstriction in mouse pulmonary artery Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H220 - H228. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sanchez, A. Skoura, M. T. Wu, B. Casserly, E. O. Harrington, and T. Hla Induction of Vascular Permeability by the Sphingosine-1-Phosphate Receptor-2 (S1P2R) and its Downstream Effectors ROCK and PTEN Arterioscler. Thromb. Vasc. Biol., June 1, 2007; 27(6): 1312 - 1318. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |